Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab? Authors’ Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13932
Full Text
Open PDFAbstract
Available in full text
Date
February 2, 2017
Authors
Publisher
Wiley